Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
367
datasets available to search
ShareScore release 0.9.0
Dataset results
367 results for “Ibrutinib”
Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02670616. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)
ClinicalTrials.gov study NCT03790332. IPD Sharing: Not stated. Countries: 13. Publications: 0.
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
ClinicalTrials.gov study NCT04439006. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT03153202. IPD Sharing: NO. Countries: 1. Publications: 0.
Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy
ClinicalTrials.gov study NCT02381080. IPD Sharing: Not stated. Countries: 3. Publications: 0.
R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL
ClinicalTrials.gov study NCT04992377. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Atrial Fibrillation in Patients Receiving Ibrutinib
ClinicalTrials.gov study NCT04407845. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants
ClinicalTrials.gov study NCT04852692. IPD Sharing: NO. Countries: 1. Publications: 0.
RICE-ibrutinib in Relapsed DLBCL
ClinicalTrials.gov study NCT02955628. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
ClinicalTrials.gov study NCT02109224. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy
ClinicalTrials.gov study NCT02966730. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study of CLL/SLL Treatment and Ibrutinib Treatment of CLL/SLL in Routine Clinical Practice
ClinicalTrials.gov study NCT04094051. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Crossover Study to Evaluate the Bioavailability of Ibrutinib Suspension and Sprinkle Formulations Compared to Capsules in Healthy Adults
ClinicalTrials.gov study NCT02390609. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04189757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India
ClinicalTrials.gov study NCT03476655. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04665115. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma After Donor Stem Cell Transplant
ClinicalTrials.gov study NCT02662296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pharmacokinetic Study in Healthy Participants to Assess the Pharmacokinetics and Safety of a Supratherapeutic Dose of PCI-32765 (Ibrutinib) Capsule and Solution Formulations Administered With Food
ClinicalTrials.gov study NCT01969266. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib
ClinicalTrials.gov study NCT03528941. IPD Sharing: NO. Countries: 1. Publications: 0.
Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years
ClinicalTrials.gov study NCT05429918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.